T. Rowe Price Associates’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Sell |
1,005,592
-882,348
| -47% | -$27.7M | ﹤0.01% | 854 |
|
|
2025
Q1 | $56M | Sell |
1,887,940
-299,590
| -14% | -$8.89M | 0.01% | 694 |
|
|
2024
Q4 | $64.5M | Buy |
2,187,530
+29,832
| +1% | +$880K | 0.01% | 671 |
|
|
2024
Q3 | $67.2M | Sell |
2,157,698
-674,971
| -24% | -$21M | 0.01% | 668 |
|
|
2024
Q2 | $96M | Buy |
2,832,669
+395,085
| +16% | +$13.4M | 0.01% | 551 |
|
|
2024
Q1 | $158M | Sell |
2,437,584
-506,990
| -17% | -$33M | 0.02% | 465 |
|
|
2023
Q4 | $201M | Buy |
2,944,574
+423,290
| +17% | +$28.9M | 0.03% | 419 |
|
|
2023
Q3 | $131M | Buy |
2,521,284
+97,864
| +4% | +$5.08M | 0.02% | 462 |
|
|
2023
Q2 | $145M | Buy |
2,423,420
+1,039,980
| +75% | +$62.4M | 0.02% | 450 |
|
|
2023
Q1 | $68.4M | Buy |
1,383,440
+49,524
| +4% | +$2.45M | 0.01% | 602 |
|
|
2022
Q4 | $76.1M | Buy |
1,333,916
+170,355
| +15% | +$9.72M | 0.01% | 550 |
|
|
2022
Q3 | $54.6M | Buy |
1,163,561
+849,662
| +271% | +$39.9M | 0.01% | 623 |
|
|
2022
Q2 | $11.7M | Sell |
313,899
-29,380
| -9% | -$1.1M | ﹤0.01% | 1295 |
|
|
2022
Q1 | $10.3M | Sell |
343,279
-36,612
| -10% | -$1.09M | ﹤0.01% | 1361 |
|
|
2021
Q4 | $13M | Buy |
379,891
+17,865
| +5% | +$612K | ﹤0.01% | 1368 |
|
|
2021
Q3 | $13.4M | Sell |
362,026
-5,278
| -1% | -$196K | ﹤0.01% | 1384 |
|
|
2021
Q2 | $14.3M | Sell |
367,304
-20,608
| -5% | -$805K | ﹤0.01% | 1369 |
|
|
2021
Q1 | $16.5M | Buy |
+387,912
| New | +$16.5M | ﹤0.01% | 1315 |
|